Novartis Forecasts Rising Profit, Buoyed by Key Drugs

Bookmark
(Bloomberg) -- Novartis AG forecast rising annual sales and profit after the Swiss drugmaker spun off its Alcon eye-care unit to sharpen focus on innovative medicines.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.